Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) EBITDA Margin (2017 - 2025)

Historic EBITDA Margin for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to 19.63%.

  • Neuronetics' EBITDA Margin rose 220800.0% to 19.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.16%, marking a year-over-year increase of 86900.0%. This contributed to the annual value of 46.15% for FY2024, which is 33300.0% down from last year.
  • As of Q3 2025, Neuronetics' EBITDA Margin stood at 19.63%, which was up 220800.0% from 21.15% recorded in Q2 2025.
  • Over the past 5 years, Neuronetics' EBITDA Margin peaked at 19.63% during Q3 2025, and registered a low of 71.47% during Q1 2022.
  • In the last 5 years, Neuronetics' EBITDA Margin had a median value of 45.99% in 2021 and averaged 45.03%.
  • Over the last 5 years, Neuronetics' EBITDA Margin had its largest YoY gain of 341000bps in 2021, and its largest YoY loss of -325700bps in 2021.
  • Over the past 5 years, Neuronetics' EBITDA Margin (Quarter) stood at 45.99% in 2021, then rose by 8bps to 42.46% in 2022, then skyrocketed by 49bps to 21.79% in 2023, then tumbled by -134bps to 51.0% in 2024, then surged by 62bps to 19.63% in 2025.
  • Its EBITDA Margin stands at 19.63% for Q3 2025, versus 21.15% for Q2 2025 and 34.45% for Q1 2025.